During the past decade, Bayview Research Group conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 18 clinical trials were completed, i.e. on average, 163.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bayview Research Group" #1 sponsor was "Pfizer" with 8 trials, followed by "BioNTech SE" with 4 trials sponsored, "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Purdue Pharma LP" with 2 trials sponsored and "Teva Branded Pharmaceutical Products R&D, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bayview Research Group" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Bayview Research Group" are "COVID-19" (3 trials), "Chronic Pain" (3 trials), "Pain" (3 trials), "SARS-CoV-2 Infection" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Bayview Research Group" in a lesser frequency.

Most popular intervention types in "Bayview Research Group" are "Drug" (16 trials), "Biological" (9 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "BNT162b2" (2 trials), "Hydrocodone ER" (2 trials), "Tolterodine Tartrate ER" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bayview Research Group" are 21 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Bayview Research Group". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Bayview Research Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Bayview Research Group, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".